Targeting olfactory receptor OR2AT4: An innovative aptamer-based treatment for hair growth promotion

Non-canonical functions of olfactory receptors, one of the largest families of GPCR receptors not confined to the olfactory system, include an intriguing role on hair physiology. Previous studies using odorant agonists of the Olfactory Receptor family 2 subfamily AT member 4 (OR2AT4) showed hair gro...

Full description

Saved in:
Bibliographic Details
Main Authors: Manuel Mataix, Nuria Illera, Inés Hidalgo, Maria del Carmen de Arriba, Elena Martín, Gerónimo Fernández, Carlos González, Fernando Larcher, Victor M. González, Marcela del Rio, Francisco Jiménez, Marta Carretero
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253125001623
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850090409921871872
author Manuel Mataix
Nuria Illera
Inés Hidalgo
Maria del Carmen de Arriba
Elena Martín
Gerónimo Fernández
Carlos González
Fernando Larcher
Victor M. González
Marcela del Rio
Francisco Jiménez
Marta Carretero
author_facet Manuel Mataix
Nuria Illera
Inés Hidalgo
Maria del Carmen de Arriba
Elena Martín
Gerónimo Fernández
Carlos González
Fernando Larcher
Victor M. González
Marcela del Rio
Francisco Jiménez
Marta Carretero
author_sort Manuel Mataix
collection DOAJ
description Non-canonical functions of olfactory receptors, one of the largest families of GPCR receptors not confined to the olfactory system, include an intriguing role on hair physiology. Previous studies using odorant agonists of the Olfactory Receptor family 2 subfamily AT member 4 (OR2AT4) showed hair growth stimulation. To develop more effective topical or systemic treatments for hair growth by specifically activating this receptor, it is crucial to identify new molecules with potent and well-defined activity. Here, we present a significant advancement in targeted therapeutic strategies for hair loss through the identification of a highly specific DNA aptamer targeting OR2AT4. The selected aptamer, designed as Ap.OR2AT4.17, effectively prolonged the anagen phase of hair growth cycle in a valuable preclinical human organ culture model. Importantly, the identified OR2AT4 aptamer was shown to be functional, leading to enhanced OR2AT4 expression in hair follicles, increased proliferation of hair matrix keratinocytes, and significant hair shaft elongation in organ-cultured human hair follicles. Notably, aptamer treatment also upregulated LL-37 and human β defensin-3 antimicrobial peptide expression, highlighting its role as a microbiota-modulating compound. These findings underscore the OR2AT4 aptamer’s potential as a novel, targeted therapy for hair loss disorders, marking a promising step forward in the field.
format Article
id doaj-art-99c09cd660a8466cbefe5f2d76eecf27
institution DOAJ
issn 2162-2531
language English
publishDate 2025-09-01
publisher Elsevier
record_format Article
series Molecular Therapy: Nucleic Acids
spelling doaj-art-99c09cd660a8466cbefe5f2d76eecf272025-08-20T02:42:34ZengElsevierMolecular Therapy: Nucleic Acids2162-25312025-09-0136310260810.1016/j.omtn.2025.102608Targeting olfactory receptor OR2AT4: An innovative aptamer-based treatment for hair growth promotionManuel Mataix0Nuria Illera1Inés Hidalgo2Maria del Carmen de Arriba3Elena Martín4Gerónimo Fernández5Carlos González6Fernando Larcher7Victor M. González8Marcela del Rio9Francisco Jiménez10Marta Carretero11Epithelial Biomedicine Division, Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, SpainEpithelial Biomedicine Division, Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, SpainUniversidad Carlos III de Madrid, ROR: https://ror.org/03ths8210, Departmento de Bioingeniería, Avenida de la Universidad, 30 (edificio Sabatini), 28911 Leganés (Madrid), SpainEpithelial Biomedicine Division, Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, SpainAptamer Group, IRYCIS-Hospital Ramón y Cajal, Madrid, SpainAptamer Group, IRYCIS-Hospital Ramón y Cajal, Madrid, SpainInstituto de Química Física Blas Cabrera, CSIC, Serrano 119, 28006 Madrid, SpainEpithelial Biomedicine Division, Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, SpainAptamer Group, IRYCIS-Hospital Ramón y Cajal, Madrid, SpainHealth Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain; Universidad Carlos III de Madrid, ROR: https://ror.org/03ths8210, Departmento de Bioingeniería, Avenida de la Universidad, 30 (edificio Sabatini), 28911 Leganés (Madrid), Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, SpainMediteknia Skin & Hair Lab, Gran Canaria, Spain; Universidad Fernando Pessoa Canarias, Gran Canaria, SpainEpithelial Biomedicine Division, Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain; Corresponding author: Marta Carretero, Epithelial Biomedicine Division, Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain.Non-canonical functions of olfactory receptors, one of the largest families of GPCR receptors not confined to the olfactory system, include an intriguing role on hair physiology. Previous studies using odorant agonists of the Olfactory Receptor family 2 subfamily AT member 4 (OR2AT4) showed hair growth stimulation. To develop more effective topical or systemic treatments for hair growth by specifically activating this receptor, it is crucial to identify new molecules with potent and well-defined activity. Here, we present a significant advancement in targeted therapeutic strategies for hair loss through the identification of a highly specific DNA aptamer targeting OR2AT4. The selected aptamer, designed as Ap.OR2AT4.17, effectively prolonged the anagen phase of hair growth cycle in a valuable preclinical human organ culture model. Importantly, the identified OR2AT4 aptamer was shown to be functional, leading to enhanced OR2AT4 expression in hair follicles, increased proliferation of hair matrix keratinocytes, and significant hair shaft elongation in organ-cultured human hair follicles. Notably, aptamer treatment also upregulated LL-37 and human β defensin-3 antimicrobial peptide expression, highlighting its role as a microbiota-modulating compound. These findings underscore the OR2AT4 aptamer’s potential as a novel, targeted therapy for hair loss disorders, marking a promising step forward in the field.http://www.sciencedirect.com/science/article/pii/S2162253125001623MT: Oligonucleotides: Therapies and Applicationsalopeciaolfactory receptorOR2AT4aptamerantimicrobial peptides
spellingShingle Manuel Mataix
Nuria Illera
Inés Hidalgo
Maria del Carmen de Arriba
Elena Martín
Gerónimo Fernández
Carlos González
Fernando Larcher
Victor M. González
Marcela del Rio
Francisco Jiménez
Marta Carretero
Targeting olfactory receptor OR2AT4: An innovative aptamer-based treatment for hair growth promotion
Molecular Therapy: Nucleic Acids
MT: Oligonucleotides: Therapies and Applications
alopecia
olfactory receptor
OR2AT4
aptamer
antimicrobial peptides
title Targeting olfactory receptor OR2AT4: An innovative aptamer-based treatment for hair growth promotion
title_full Targeting olfactory receptor OR2AT4: An innovative aptamer-based treatment for hair growth promotion
title_fullStr Targeting olfactory receptor OR2AT4: An innovative aptamer-based treatment for hair growth promotion
title_full_unstemmed Targeting olfactory receptor OR2AT4: An innovative aptamer-based treatment for hair growth promotion
title_short Targeting olfactory receptor OR2AT4: An innovative aptamer-based treatment for hair growth promotion
title_sort targeting olfactory receptor or2at4 an innovative aptamer based treatment for hair growth promotion
topic MT: Oligonucleotides: Therapies and Applications
alopecia
olfactory receptor
OR2AT4
aptamer
antimicrobial peptides
url http://www.sciencedirect.com/science/article/pii/S2162253125001623
work_keys_str_mv AT manuelmataix targetingolfactoryreceptoror2at4aninnovativeaptamerbasedtreatmentforhairgrowthpromotion
AT nuriaillera targetingolfactoryreceptoror2at4aninnovativeaptamerbasedtreatmentforhairgrowthpromotion
AT ineshidalgo targetingolfactoryreceptoror2at4aninnovativeaptamerbasedtreatmentforhairgrowthpromotion
AT mariadelcarmendearriba targetingolfactoryreceptoror2at4aninnovativeaptamerbasedtreatmentforhairgrowthpromotion
AT elenamartin targetingolfactoryreceptoror2at4aninnovativeaptamerbasedtreatmentforhairgrowthpromotion
AT geronimofernandez targetingolfactoryreceptoror2at4aninnovativeaptamerbasedtreatmentforhairgrowthpromotion
AT carlosgonzalez targetingolfactoryreceptoror2at4aninnovativeaptamerbasedtreatmentforhairgrowthpromotion
AT fernandolarcher targetingolfactoryreceptoror2at4aninnovativeaptamerbasedtreatmentforhairgrowthpromotion
AT victormgonzalez targetingolfactoryreceptoror2at4aninnovativeaptamerbasedtreatmentforhairgrowthpromotion
AT marceladelrio targetingolfactoryreceptoror2at4aninnovativeaptamerbasedtreatmentforhairgrowthpromotion
AT franciscojimenez targetingolfactoryreceptoror2at4aninnovativeaptamerbasedtreatmentforhairgrowthpromotion
AT martacarretero targetingolfactoryreceptoror2at4aninnovativeaptamerbasedtreatmentforhairgrowthpromotion